Directional Healthcare provides expertise and leadership in defining and commercializing new medical technologies. Our strengths are in launching and optimizing new products, bringing them from development to clinical practice.
We provide direct support to execute:
* product development strategy
* marketing strategy
* market segmentation
* new drug and device product execution
* business line P&L assessment
* business development
In addition to these services, Directional Healthcare has the expertise to both establish the framework for marketing strategy and to execute on that strategy. This can take the form of establishing relationships with key opinion leaders, forming speaker panels, developing launch materials, developing expert panels, executing development processes, and executing integrated marketing communications.
The firm was formed to address the needs of emerging companies developing product technology which, in turn, improves quality and effectiveness in healthcare and life science delivery. The challenge for many companies, especially early-stage companies, is establishing a product development strategy that is focused on meeting clinical needs in the context of profitable growth. Directional Healthcare works with client companies to set the strategic framework, establish program priorities, and develop an execution pathway that will yield clinical and business results.
Advisors
Directional Healthcare is led by Roy Wallen. He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns. His experience includes company formation, raising capital (grants and equity-based), establishing business plans then executing on those plans, and successful completion of multiple market launches. With an undergraduate degree in electrical engineering and a biomedical focus, as well as graduate studies in biomedical engineering and business, Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use. In addition to successful launches in the United States, Roy spent approximately eight years in Europe where he investigated new technologies and launched several new products for a large, global company; established a European presence for a start-up company seeking its initial public offering; and supported, built, and maintained sales and distribution channels. He has overseen the successful launch of products in Japan and southeast Asia through distribution partners by establishing the import, regulatory, safety, and reimbursement elements needed for successful commercialization. Roy has published both peer-reviewed papers and abstracts and short papers and is a regular conference presenter, all on subjects related to healthcare technology and its implementation.
Mark Wickham, BSc, PhD, MBA is the Principal at Alacramed Ltd., a consultancy registered in England & Wales, and is based in Cambridge, UK. He has spent over 25 years in the medical device industry in Europe and the USA where he has gained experience leading companies and large teams of professional staff. He joined Alacrita in January 2014 to lead the firm’s medtech consulting practice and then spun out AlacraMed to provide enhanced focus on medtech consulting in October 2015. Mark has had senior operational roles in large organisations including Smith & Nephew plc, London International Group plc and Bespak plc, as well as experience in founding, fund raising and leading start-ups bio-del Ltd and B1 Medical Ltd. He also has consulting experience gained at PA Consulting Group and The Technology Partnership. Mark has supported a broad range of companies and led projects in orthopaedics, sports medicine, wound management, drug delivery devices, cardiology and diagnostics. His consulting practice focuses on technical and commercial due diligence, business development, innovation strategies and product development, and his operational experience covers starting new businesses through to management of large teams of professional staff and facilities.